Steven L. Hoerter, Director at MBX Biosciences, Inc. (MBX), bought 20,000 shares at $13.25 ($265K) on 2025-10-17, disclosed to the SEC on 2025-10-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2023-03-23 | $117K | — | Filing → |
| DCPH | SELL | 2023-02-16 | $481K | — | Filing → |
| AGIO | SELL | 2019-03-05 | $670K | — | Filing → |